NYSE ARCA | ETF
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index.
It will normally invest at least 80% of its net assets in securities that comprise the underlying index.
The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of theU. S.
Food and Drug Administration clinical trials.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
VRNA | Verona Pharma PLC ADR | Healthcare | Biotechnology | 6.33% |
CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 5.36% |
RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 4.38% |
CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 4.07% |
SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 3.93% |
RYTM | Rhythm Pharmaceuticals Inc | Healthcare | Biotechnology | 3.46% |
NUVL | Nuvalent Inc | Healthcare | Biotechnology | 3.38% |
AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.38% |
ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.14% |
PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 2.92% |
IMVT | Immunovant Inc | Healthcare | Biotechnology | 2.89% |
CYTK | Cytokinetics Inc | Healthcare | Biotechnology | 2.78% |
ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 2.73% |
KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 2.68% |
MTSR | Metsera, Inc. Common Stock | Healthcare | Biotechnology | 2.60% |
AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 2.58% |
MRUS | Merus BV | Healthcare | Biotechnology | 2.55% |
PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 2.42% |
ACLX | Arcellx Inc | Healthcare | Biotechnology | 2.39% |
RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 2.39% |